Trials / Recruiting
RecruitingNCT06936943
ONO-4538 Study in Patients With Richter's Transformation
A Multicenter, Open-label, Uncontrolled Study to Evaluate the Efficacy and Safety of ONO-4538 in Patients With Richter's Transformation
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-4538 | every 4 weeks |
Timeline
- Start date
- 2025-11-19
- Primary completion
- 2029-07-31
- Completion
- 2030-07-31
- First posted
- 2025-04-20
- Last updated
- 2026-02-13
Locations
10 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT06936943. Inclusion in this directory is not an endorsement.